Clinical Trials Articles
CSL Behring has enrolled its first patient in the pivotal pediatric PhaseIII study to evaluate the efficacy, safety and pharmacokinetics of its novel investigational recombinant factor VIII single chain (rVIII-SingleChain) for the treatment of previously treated children (up to 11 years) with severe hemophilia A.
Positive results have been shown with the completion of pathfinder2 for hemophilia A patients 12 years and older.
Novovax Inc.’s quadrivalent seasonal influenza virus-like particle (VLP) vaccine demonstrated the company’s PhaseII clinical trial’s primary endpoint of safety and immunogenicity of three ascending dose levels.
Grifols has launched a new study into methods of treatment for Alzheimer’s disease.
A Phase II clinical trial that is testing the success of a pancreatic cancer vaccine is giving researchers hope that the treatment might be ready for wide distribution within the next couple of years.
Danish investigators conducted a trial of adult patients to test whether subcutaneous immunoglobulin therapy is a viable alternative to intravenous immunoglobulin therapy in chronic inflammatory demyelinating polyradiculoneuropathy.
U.S. and Italian investigators performed a meta-analysis of randomized controlled trials to quantify the effect of albumin administration on renal impairment and mortality in patients with spontaneous bacterial peritonitis.